CLSD

Clearside Biomedical Stock Price

1.74
0.00 (0.0%)
Upgrade to Real-Time
Regular Market
1.74
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Clearside Biomedical Inc CLSD NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.00 0.0% 1.74 1.72 1.75 1.74 1.74 10:37:05
Bid Price Ask Price Spread Spread % News
1.73 1.75 0.02 1.14% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
217 83,738 $ 1.74 $ 145,716 425,364 0.56 - 4.13
Last Trade Time Type Quantity Stock Price Currency
10:42:54 2,000 $ 1.74 USD

Clearside Biomedical Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 94.50M 54.31M 43.77M $ 2.17M $ - -0.83 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% -42.14k 7.20%

more financials information »

Clearside Biomedical News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CLSD Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.961.971.661.81286,140-0.22-11.22%
1 Month1.952.121.661.94291,562-0.21-10.77%
3 Months2.142.551.662.02415,032-0.40-18.69%
6 Months2.104.131.102.43625,004-0.36-17.14%
1 Year1.204.130.561.83821,5760.5445.0%
3 Years9.7915.3290.563.89595,513-8.05-82.23%
5 Years8.0025.080.564.42476,540-6.26-78.25%

Clearside Biomedical Description

Clearside Biomedical Inc is the United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye. The product candidates of the company focus on a disease affecting the retina and aim to restore or improve visual function primarily by reducing the macular edema associated with several diseases affecting vision.


Your Recent History
NASDAQ
CLSD
Clearside ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.